Globitair

Leader meetings

Kobayashi in $3.2 Billion Buyout Talks After Red-Yeast Case

BloombergJapan

Kobayashi Pharmaceutical Co., the Japanese health products company that was at the center of a supplement contamination scandal involving suspected deaths, is said to be considering a potential buyout offer of more than ¥500 billion ($3.2 billion) by private equity investors.

Read the full story at BloombergOpen in the live monitor

Related discussion groups

No group discusses this yet. Start a discussion group and attach this story.

More news about Japan

More on Leader meetings